![]() |
![]() ![]() ![]() |
||||
![]() |
Michael F. Clarke,
M.D.
Our lab has developed a technique that allows the isolation and characterization of tumorigenic and non-tumorigenic populations of cancer cells present in human breast cancer tumors. Only a small minority of cancer cells had the capacity to form new tumors in a xenograft model. This tumorigenic cell population could be identified prospectively and consistently had definable and identical phenotype. The tumorigenic cells displayed stem cell-like properties in that they were capable of generating new tumors containing additional stem cells as well as regenerating the phenotypically mixed populations of non-tumorigenic cells present in the original tumor. The expression of potential therapeutic targets differed between the tumorigenic and non-tumorigenic populations.Effective treatment of breast cancer will require therapeutic strategies that are able to target and eliminate this tumorigenic subset of cells. Representative publications: Weber, B.L., Westin, E. and Clarke, M.F.: Differentiation of mouse erythroleukemia
cells enhanced by alternatively spliced c-myb mRNA. Science, 249:1291-1293,
1990. |
|
About Us | Research Opportunities | Faculty | Graduate Students | Admissions | Coursework | Immunology Seminars | Life in A2 UM Gateway | UM Medical School | Program in Biological Sciences | UM Health System Web Design by BMC Media Copyright © 2002 The Regents of the University of Michigan |